Evidence map›Paper›PMID 28603612›Full record

ArticleAnnals of medicine and surgery (2012)2017

Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students.

Magdalini Filippiadou, Dimitrios Kouvelas, Georgios Garyfallos, Ioannis Tsakiridis, Dimitrios Tzachanis, Dimitrios Spachos, Georgios Papazisis

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Magdalini FilippiadouDepartment of Clinical Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Greece.
Dimitrios KouvelasDepartment of Clinical Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Greece.
Georgios Garyfallos2nd University Department of Psychiatry, Psychiatric Hospital of Thessaloniki, Greece.
Ioannis TsakiridisDepartment of Clinical Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Greece.
Dimitrios TzachanisDepartment of Clinical Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Greece.
Dimitrios SpachosDepartment of Medical Physics, Faculty of Medicine, Aristotle University of Thessaloniki, Greece.
Georgios PapazisisDepartment of Clinical Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Greece.
Aristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedical students are targeted by the pharmaceutical industry and are exposed to their marketing strategies even in the preclinical years of study. The marketing strategies used by pharmaceutical companies with physicians are also applied to students, affecting their future prescribing behaviour, and include low-cost non-educational gifts, travel expenses and conferences registration fees. In Greece, there are no national or institutional regulations and guidelines concerning drug company-medical student interactions. This study is the first time this estimate has been made in Greece and assessed a) the interactions between pharmaceutical companies and medical students, and b) students' attitudes towards pharmaceutical marketing.

methodsA sampling of undergraduate medical students completed an anonymous, self-administered, web-based survey. The first part of the survey investigated the interaction between the students and pharmaceutical companies; the possible answers were the binomial variables 'yes' or 'no'. The second part assessed the students' opinions of pharmaceutical company marketing and the answer options were 'agree', 'don't know/don't answer' and 'disagree'.

resultsThe survey was completed by 412 undergraduate medical students (mean age 22 ± 2.2 years, 52.7% were women); the overall response rate was 58.9%. Although the majority did not consider accepting gifts and meals from drug companies as ethical, most of them (59%) had accepted meals and low-cost non-educational gifts, especially the clinical-level students. Further, 52,6% of the students did not believe that accepting gifts from pharmaceutical companies would affect their own prescription behaviour, whereas surprisingly they held the opposite opinion of their classmates. The vast majority (85.9%) agreed that sponsored lectures were biased in favour of a company's products; however, 47.6% agreed that promotional material is useful for learning about new medications and 34.5% believed that medical schools should allow drug company representatives to interact with students.

conclusionOur results suggest that medical students in Greece are notably exposed to pharmaceutical industry marketing and their conflicting answers demonstrate that they are inadequately prepared for this interaction. Interventions are needed so that students are prepared and able to manage these interactions critically.

Indexed as

Drug companyGiftsGreeceMarketingMedical studentsPharmaceutical industry

Identifiers

PMID28603612
PMCPMC5454084
OpenAlexW2617288935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.